You’ve finally turned your idea into a real business. You’ve got customers, maybe a Stripe account, maybe even a few ...
Amgen (NASDAQ:AMGN) today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha® (evolocumab) achieved statistically significant and clinically meaningful ...